|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brennan K, Holsinger C, Dosiou C, Sunwoo
JB, Akatsu H, Haile R and Gevaert O: Development of prognostic
signatures for intermediate-risk papillary thyroid cancer. BMC
Cancer. 16:7362016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang H, Teng X and Liu Z, Zhang L and Liu
Z: Gene expression profile analyze the molecular mechanism of CXCR7
regulating papillary thyroid carcinoma growth and metastasis. J Exp
Clin Cancer Res. 34:162015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carling T and Udelsman R: Thyroid cancer.
Annu Rev Med. 65:125–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qu T, Li YP, Li XH and Chen Y:
Identification of potential biomarkers and drugs for papillary
thyroid cancer based on gene expression profile analysis. Mol Med
Rep. 14:5041–5048. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prasad NB, Somervell H, Tufano RP, Dackiw
AP, Marohn MR, Califano JA, Wang Y, Westra WH, Clark DP, Umbricht
CB, et al: Identification of genes differentially expressed in
benign versus malignant thyroid tumors. Clin Cancer Res.
14:3327–3337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, He M, Hou Y, Liang B, Zhao L, Ma S,
Yu Y and Liu X: Expression profiles of microRNAs and their target
genes in papillary thyroid carcinoma. Oncol Rep. 29:1415–1420.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu Y, Wang H, Chen E, Xu Z, Chen B and Lu
G: Candidate microRNAs as biomarkers of thyroid carcinoma: A
systematic review, meta-analysis, and experimental validation.
Cancer Med. 5:2602–2614. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang S, Wang Y, Chen M, Sun L, Han J,
Elena VK and Qiao H: CXCL12 methylation-mediated epigenetic
regulation of gene expression in papillary thyroid carcinoma. Sci
Rep. 7:440332017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen LL, Gao GX, Shen FX, Chen X, Gong XH
and Wu WJ: SDC4 gene silencing favors human papillary thyroid
carcinoma cell apoptosis and inhibits epithelial mesenchymal
transition via Wnt/β-catenin pathway. Mol Cells. 41:853–867.
2018.PubMed/NCBI
|
|
11
|
Gugnoni M, Sancisi V, Gandolfi G, Manzotti
G, Ragazzi M, Giordano D, Tamagnini I, Tigano M, Frasoldati A,
Piana S and Ciarrocchi A: Cadherin-6 promotes EMT and cancer
metastasis by restraining autophagy. Oncogene. 36:667–677. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reiner A, Yekutieli D and Benjamini Y:
Identifying differentially expressed genes using false discovery
rate controlling procedures. Bioinformatics. 19:368–375. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Min XS, Huang P, Liu X, Dong C, Jiang XL,
Yuan ZT, Mao LF and Chang S: Bioinformatics analyses of significant
prognostic risk markers for thyroid papillary carcinoma. Tumour
Biol. 36:7457–7463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu W, Li C and Ai Z: Candidate agents for
papillary thyroid cancer identified by gene expression analysis.
Pathol Oncol Res. 19:597–604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dom G, Tarabichi M, Unger K, Thomas G,
Oczko-Wojciechowska M, Bogdanova T, Jarzab B, Dumont JE, Detours V
and Maenhaut C: A gene expression signature distinguishes normal
tissues of sporadic and radiation-induced papillary thyroid
carcinomas. Br J Cancer. 107:994–1000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giordano TJ, Kuick R, Thomas DG, Misek DE,
Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, et al:
Molecular classification of papillary thyroid carcinoma: Distinct
BRAF, RAS, and RET/PTC mutation-specific gene expression profiles
discovered by DNA microarray analysis. Oncogene. 24:6646–6656.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He H, Jazdzewski K, Li W, Liyanarachchi S,
Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al:
The role of microRNA genes in papillary thyroid carcinoma. Proc
Natl Acad Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu X, Yao J and Tian W: Microarray
technology to investigate genes associated with papillary thyroid
carcinoma. Mol Med Rep. 11:3729–3733. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tu Y, Fan G, Xi H, Zeng T, Sun H, Cai X
and Kong W: Identification of candidate aberrantly methylated and
differentially expressed genes in thyroid cancer. J Cell Biochem.
11:8797–8806. 2018. View Article : Google Scholar
|
|
21
|
Lu Z, Sheng J, Zhang Y, Deng J, Li Y, Lu
A, Zhang J, Yu H, Zhang M, Xiong Z, et al: Clonality analysis of
multifocal papillary thyroid carcinoma by using genetic profiles. J
Pathol. 239:72–83. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu J, Mai W, Cui Y and Kong L: Key genes
and pathways predicted in papillary thyroid carcinoma based on
bioinformatics analysis. J Endocrinol Invest. 39:1285–1293. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ,
Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, et al: Hepatocellular
carcinoma associated microRNA expression signature: Integrated
bioinformatics analysis, experimental validation and clinical
significance. Oncotarget. 6:25093–25108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan Z, Fang Q, Zhang Y, Li L and Huang P:
Identification of key pathways and drug repurposing for anaplastic
thyroid carcinoma by integrated bioinformatics analysis. Zhejiang
Da Xue Xue Bao Yi Xue Ban. 47:187–193. 2018.(In Chinese).
PubMed/NCBI
|
|
25
|
Wei W, Chen Y, Xu J, Zhou Y, Bai X, Yang M
and Zhu J: Identification of biomarker for cutaneous squamous cell
carcinoma using microarray data analysis. J Cancer. 9:400–406.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen F, Shen C, Wang X, Wang H, Liu Y, Yu
C, Lv J, He J and Wen Z: Identification of genes and pathways in
nasopharyngeal carcinoma by bioinformatics analysis. Oncotarget.
8:63738–63749. 2017.PubMed/NCBI
|
|
27
|
Yan R, Yang T, Zhai H, Zhou Z, Gao L and
Li Y: MicroRNA- 150-5p affects cell proliferation, apoptosis, and
EMT by regulation of the BRAFV600E mutation in papillary
thyroid cancer cells. J Cell Biochem. 119:8763–8772. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Yang L and Liu Z, Liu C, Teng X,
Zhang L, Yin B and Liu Z: iTRAQ-coupled 2D LC/MS-MS analysis of
CXCR7-transfected papillary thyroid carcinoma cells: A new insight
into CXCR7 regulation of papillary thyroid carcinoma progression
and identification of potential biomarkers. Oncol Lett.
14:3734–3740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Diao Y, Fu H and Wang Q: MiR-221
exacerbate cell proliferation and invasion by targeting TIMP3 in
papillary thyroid carcinoma. Am J Ther. 24:e317–e328. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Z, Zhang J, Gao J and Li Y:
MicroRNA-4728 mediated regulation of MAPK oncogenic signaling in
papillary thyroid carcinoma. Saudi J Biol Sci. 25:986–990. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JC, Zhao JT, Gundara J, Serpell J,
Bach LA and Sidhu S: Papillary thyroid cancer-derived exosomes
contain miRNA-146b and miRNA-222. J Surg Res. 196:39–48. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han M, Chen L and Wang Y: miR-218
overexpression suppresses tumorigenesis of papillary thyroid cancer
via inactivation of PTEN/PI3K/AKT pathway by targeting Runx2. Onco
Targets Ther. 11:6305–6316. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zheng Z, Zhou X, Cai Y, Chen E, Zhang X,
Wang O, Wang Q and Liu H: TEKT4 promotes papillary thyroid cancer
cell proliferation, colony formation, and metastasis through
activating PI3K/Akt pathway. Endocr Pathol. 29:310–316. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu ST, Zhong Q, Chen RH, Han P, Li SB,
Zhang H, Yuan L, Xia TL, Zeng MS and Huang XM: CRLF1 promotes
malignant phenotypes of papillary thyroid carcinoma by activating
the MAPK/ERK and PI3K/AKT pathways. Cell Death Dis. 9:3712018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu J, Cai J, Jin X, Yang J, Shen Q, Ding X
and Liang Y: PIG3 plays an oncogenic role in papillary thyroid
cancer by activating the PI3K/AKT/PTEN pathway. Oncol Rep.
34:1424–1430. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao H and Li H: Network-based
meta-analysis in the identification of biomarkers for papillary
thyroid cancer. Gene. 661:160–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alao JP: The regulation of cyclin D1
degradation: Roles in cancer development and the potential for
therapeutic invention. Mol Cancer. 6:242007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jeon S, Kim Y, Jeong YM, Bae JS and Jung
CK: CCND1 splice variant as a novel diagnostic and predictive
biomarker for thyroid cancer. Cancers (Basel). 10:2018. View Article : Google Scholar
|
|
39
|
Yin Y, Hong S, Yu S, Huang Y, Chen S, Liu
Y, Zhang Q, Li Y and Xiao H: MiR-195 inhibits tumor growth and
metastasis in papillary thyroid carcinoma cell lines by targeting
CCND1 and FGF2. Int J Endocrinol. 2017:61804252017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou Y, Lu L, Jiang G, Chen Z, Li J, An P,
Chen L, Du J and Wang H: Targeting CDK7 increases the stability of
Snail to promote the dissemination of colorectal cancer. Cell Death
Differ. 26:1442–1452. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lin T, Zhang B and He H: Identification of
genes correlated with oral squamous cell carcinoma. J Cancer Res
Ther. 14:S675–S679. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Y, Xu H, Zhu B, Qiu Z and Lin Z:
Systematic identification of the key candidate genes in breast
cancer stroma. Cell Mol Biol Lett. 23:442018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shou X, Li Y, Hu W, Ye T, Wang G, Xu F,
Sui M and Xu Y: A six-gene Assay as a new biomarker in the blood of
patients with colorectal cancer: Establishment and clinical
validation. Mol Oncol. 13:781–791. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li L, Cai S, Liu S, Feng H and Zhang J:
Bioinformatics analysis to screen the key prognostic genes in
ovarian cancer. J Ovarian Res. 10:272017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jasbi P, Wang D, Cheng SL, Fei Q, Cui JY,
Liu L, Wei Y, Raftery D and Gu H: Breast cancer detection using
targeted plasma metabolomics. J Chromatogr B Analyt Technol Biomed
Life Sci. 1105:26–37. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Johann DJ Jr, McGuigan MD, Patel AR, Tomov
S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR,
Petricoin EF III and Liotta LA: Clinical proteomics and biomarker
discovery. Ann NY Acad Sci. 1022:295–305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Port M, Boltze C, Wang Y, Röper B, Meineke
V and Abend M: A radiation-induced gene signature distinguishes
post-Chernobyl from sporadic papillary thyroid cancers. Radiat Res.
168:639–649. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang K, Liu J, Li C, Peng X, Li H and Li
Z: Identification and validation of potential target genes in
papillary thyroid cancer. Eur J Pharmacol. 843:217–225. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang X, Hu Y, Shi H, Zhang C, Wang Z, Liu
X, Chen H, Zhang L and Cui D: The diagnostic value of TROP-2, SLP-2
and CD56 expression in papillary thyroid carcinoma. Eur Arch
Otorhinolaryngol. 275:2127–2134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Stephen JK, Chen KM, Merritt J, Chitale D,
Divine G and Worsham MJ: Methylation markers differentiate thyroid
cancer from benign nodules. J Endocrinol Invest. 41:163–170. 2018.
View Article : Google Scholar : PubMed/NCBI
|
